Global Artificial Saliva Market Size By Type (Oral Spray, Oral Solution), By Application (Adult, Paediatric), By Region, And Segment Forecasts, 2023 to 2032

The Global Artificial Saliva Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 3.6 billion by 2031, growing at a CAGR of 6.8% during the forecast period from 2023 to 2031. The market is witnessing significant growth due to increasing cases of xerostomia (dry mouth), driven by rising incidences of chronic diseases such as diabetes, cancer, and neurological disorders. The demand for artificial saliva is further propelled by the expanding geriatric population, higher awareness about oral health, and ongoing innovations in oral care formulations.

Drivers:

1. Increasing Prevalence of Xerostomia-Linked Disorders:

Chronic illnesses such as diabetes, Sjögren’s syndrome, and cancer treatments like chemotherapy and radiation contribute significantly to dry mouth, necessitating artificial saliva products for symptom management.

2. Growing Geriatric Population:

With aging, natural saliva production decreases, increasing the use of saliva substitutes. This trend is evident in developed nations with aging populations, such as Japan, Germany, and the U.S.

3. Technological Advancements in Formulations:

Product innovation, such as enzyme-enriched sprays and long-acting gels, has enhanced the effectiveness and convenience of artificial saliva, leading to higher adoption rates.

Restraints:

1. Short Duration of Relief & Repetitive Application:

Artificial saliva products provide temporary relief, often requiring multiple applications per day, which can impact user convenience and adherence.

2. Limited Awareness in Low-Income Regions:

In many emerging and underdeveloped markets, awareness about xerostomia management and availability of artificial saliva solutions remains low, restraining market penetration.

Opportunity:

1. Expansion into Emerging Economies:

Countries in Asia-Pacific, Latin America, and the Middle East offer vast untapped markets, driven by rising healthcare access and increasing investment in oral care education.

2. Development of Long-Lasting Bioengineered Solutions:

Biotechnology advancements are paving the way for next-generation saliva substitutes that mimic natural saliva more closely and offer prolonged hydration effects.

Market by System Type Insights:

By system type, the gel-based artificial saliva segment held the largest market share in 2023. These products are preferred due to their longer retention in the oral cavity and better moisturizing capabilities. However, the spray segment is expected to grow at the fastest pace due to its ease of use, portability, and growing consumer preference for on-the-go hydration.

Market by End-use Insights:

The hospital pharmacy segment dominated the market in 2023, attributed to physician recommendations and higher product availability for inpatients undergoing treatments like chemotherapy. The online pharmacy segment is anticipated to witness robust growth, fueled by rising e-commerce penetration and consumer inclination towards convenience and discrete purchases.

Market by Regional Insights:

North America held the dominant position in the artificial saliva market in 2023, owing to its advanced healthcare infrastructure, higher disease awareness, and large aging population. Asia-Pacific is forecasted to be the fastest-growing region, driven by increasing healthcare spending, expanding geriatric base, and growing diagnosis rates of xerostomia.

Competitive Scenario:

Key players in the Global Artificial Saliva Market include GlaxoSmithKline plc, Fresenius Kabi, Cipla Ltd., Biocosmetics Laboratories, Parnell Pharmaceuticals, Forward Science, and Fresenius SE & Co. KGaA. These companies are focusing on research and development, product innovation, and strategic partnerships to capture greater market share.

Key Market Developments:

In 2024, GlaxoSmithKline introduced a new enzyme-based artificial saliva gel targeting patients with Sjögren’s syndrome.

In 2023, Cipla Ltd. expanded its artificial saliva product portfolio into Southeast Asian markets via strategic local partnerships.

In 2022, Forward Science received FDA clearance for an advanced moisturizing spray featuring nanotechnology for improved absorption and longer hydration.

Scope of Work – Global Artificial Saliva Market

FAQs:

1) What is the current market size of the Global Artificial Saliva Market?

The Global Artificial Saliva Market was valued at USD 2.1 billion in 2023.

2) What is the major growth driver of the Global Artificial Saliva Market?

The major growth driver is the increasing prevalence of xerostomia due to chronic diseases and the expanding aging population.

3) Which is the largest region during the forecast period in the Global Artificial Saliva Market?

North America is the largest region, driven by advanced healthcare systems and high disease awareness.

4) Which segment accounted for the largest market share in the Global Artificial Saliva Market?

The gel-based artificial saliva segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Artificial Saliva Market?

Key players include GlaxoSmithKline plc, Fresenius Kabi, Cipla Ltd., Biocosmetics Laboratories, and Forward Science.